Log In

About the program

Heart Education USA is an educational program created to explore emerging data in hypertrophic cardiomyopathy and heart failure. Learn from and engage directly with expert faculty to stay abreast of evolving best practice in cardiology care.

Join our mailing list

cardiology care

The aim of Heart Education USA is to effect positive change in outcomes across the country through increased disease awareness and adoption of emerging clinical best practice in cardiology care. As a result, we hope to reduce hospitalisation and lower mortality rates.

Our program is designed for all healthcare professionals across the USA involved with diagnosis and management of cardiology patients. This includes but is not limited to: cardiologists, cardiology nurse specialists and cardiology pharmacists.


Hypertrophic cardiomyopathy (HCM) is a complex type of heart disease that affects the heart muscle. Although HCM is a relatively rare genetic heart disease, it affects over 1 in 500 people in the general population. Current data estimates that 700,000–725,000 people in the United States have HCM.

People who have HCM may experience a range of symptoms which can include shortness of breath and chest pain. However, HCM may be overlooked as symptoms overlap with other common heart conditions and as a result, many patients with HCM are often misdiagnosed.

Heart failure

Although non-vitamin K antagonist oral anticoagulants (NOACs), also called direct oral anticoagulants (DOACs), have been available for a decade, myths surrounding their use have prevented them reaching all patients that would benefit. With changing recommendations and new data available all the time, we provide a reliable resource for cutting edge learning in heart failure.

At present, we focus on three main topics:

  • The use of oral anticoagulants in patients with atrial fibrillation
  • NOAC reversal agents
  • Additional considerations in patient management, such as when surgery is indicated or when internal bleeding presents

Prophylactic anticoagulation is also being explored in conditions such as embolic strokes of undetermined source (ESUS) or when there is a risk of a patient developing venous thromboembolism (VTE). As the indications for thromboprophylaxis expand, so too will the breadth of our content.

What we do


Journal Clubs

Exploring the latest emerging data with the paper’s author


Free-to-access digital education to learn at your own convenience

Case studies

Examine complex issues in real-life applications


Network with leading experts and like-minded cardiology peers


How it works



Register for free-to- access materials anywhere, any time! Sign-up to our newsletter to be notified of live educational activities


Complete modules and attend live events

Save your progress if you are unable to complete it in one sitting and revisit completed modules anytime to refresh your memory on your chosen topics and attend our live events to stay abreast of the latest emerging clinical data


Complete feedback form in application for CPD certificate

For educational modules where accreditation is applicable, once you complete the module, submit the feedback form. A certificate confirming module completion will then be sent to the email address provided on the feedback form


CPD Points and Certficate

Continuing Professional Development (CPD) are learning activities professionals engage in to develop and improve their abilities. CPD enables learning that is beyond mandatory training with different methodologies such as workshops, events, e-learning programs and more.

Earn more CPD points here